Document Detail


Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.
MedLine Citation:
PMID:  9365448     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The reliability of a clinical diagnosis of heart failure in primary care is poor. Concentrations of natriuretic peptides are high in heart failure. This population-based study examined the predictive value of natriuretic peptides in patients with a new primary-care diagnosis of heart failure. METHODS: Concentrations of plasma atrial (ANP and N-terminal ANP) and B-type (BNP) natriuretic peptides were measured by radioimmunoassay in 122 consecutive patients referred to a rapid-access heart-failure clinic with a new primary-care diagnosis of heart failure. On the basis of clinical assessment, chest radiography, and transthoracic echocardiography, a panel of three cardiologists decided that 35 (29%) patients met the case definition for new heart failure. ANP and NT-ANP results were available for 117 patients (34 with heart failure) and BNP results for 106 (29 with heart failure). FINDINGS: Geometric mean concentrations of natriuretic peptides were much higher in patients with heart failure than in those with other diagnoses (29.2 vs 12.4 pmol/L for ANP; 63.9 vs 13.9 pmol/L for BNP; 1187 vs 410.6 pmol/L for NT-ANP; all p < 0.001). At cut-off values chosen to give negative predictive values for heart failure of 98% (ANP > or = 18.1 pmol/L, NT-ANP > or = 537.6 pmol/L, BNP > or = 22.2 pmol/L), the sensitivity, specificity, and positive predictive value for ANP were 97%, 72%, and 55%; for NT-ANP 97%, 66%, and 54%; and for BNP 97%, 84%, and 70%. Addition of ANP or NT-ANP concentration or both did not improve the predictive power of a logistic regression model containing BNP concentration alone. INTERPRETATION: In patients with symptoms suspected by a general practitioner to be due to heart failure, plasma BNP concentration seems to be a useful indicator of which patients are likely to have heart failure and require further clinical assessment.
Authors:
M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Related Documents :
15643118 - Plasma bnp in patients on maintenance haemodialysis: a guide to management?
11516028 - Neurohumoral activation in percutaneous coronary interventions: apropos of ten vasoacti...
18722158 - Diagnostic and prognostic significance of plasma n-terminal-pro-brain natriuretic pepti...
14522568 - N-terminal pro-brain natriuretic peptide. a new gold standard in predicting mortality i...
18838148 - Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in ...
9389088 - Immunohistochemical analysis of growth factor expression and localization in gastric co...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Lancet     Volume:  350     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1997 Nov 
Date Detail:
Created Date:  1997-12-05     Completed Date:  1997-12-05     Revised Date:  2009-09-29    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1349-53     Citation Subset:  AIM; IM    
Affiliation:
Imperial College School of Medicine, National Heart and Lung Institute, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Atrial Natriuretic Factor / blood*
Female
Heart Failure / blood,  diagnosis*
Humans
Male
Middle Aged
Primary Health Care
Radioimmunoassay
Reproducibility of Results
Grant Support
ID/Acronym/Agency:
//Wellcome Trust
Chemical
Reg. No./Substance:
85637-73-6/Atrial Natriuretic Factor
Comments/Corrections
Comment In:
Lancet. 1998 Feb 7;351(9100):444; author reply 445   [PMID:  9482328 ]
Lancet. 1998 Feb 7;351(9100):444-5; author reply 445   [PMID:  9482329 ]
Lancet. 1998 Jan 31;351(9099):371; author reply 371-2   [PMID:  9652647 ]
Lancet. 1998 Feb 7;351(9100):444; author reply 445   [PMID:  9482327 ]
Lancet. 1998 Feb 7;351(9100):444; author reply 445   [PMID:  9482326 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Short-term improvements in public health from global-climate policies on fossil-fuel combustion: an ...
Next Document:  Randomised trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in low...